Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics von Bogen, Jan P., Grzeschik, Julius, Jakobsen, Joern, Bahre, Alexandra, Hock, Bjorn, Kolmar, Harald

Volltext

Synergistic Antitumor Effect of Bispecific CD19 x CD3 and CD19 x CD16 Diabodies in a Preclinical Model of Non-Hodgkin's Lymphoma von Kipriyanov, Sergey M, Cochlovius, Bjorn, Schafer, Holger J, Moldenhauer, Gerhard, Bahre, Alexandra, Le Gall, Fabrice, Knackmuss, Stefan, Little, Melvyn

Volltext

Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma von Kipriyanov, Sergey M., Cochlovius, Björn, Schäfer, Holger J., Moldenhauer, Gerhard, Bähre, Alexandra, Le Gall, Fabrice, Knackmuss, Stefan, Little, Melvyn

Volltext

Combined effect of recombinant CD19 x CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma von Schlenzka, Jana, Moehler, Thomas M, Kipriyanov, Sergey M, Kornacker, Martin, Benner, Axel, Bähre, Alexandra, Stassar, Marike J J G, Schäfer, Holger J, Little, Melvyn, Goldschmidt, Hartmut, Cochlovius, Björn

Volltext

Recombinant chimeric OKT3/IgM antibodies for immune suppression: evaluation in a human CD3 transgenic mouse model von Choi, Ingrid, Schmitt, Wolfgang E, Bähre, Alexandra, Little, Melvyn, Cochlovius, Björn

Volltext

Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma von Schlenzka, Jana, Moehler, Thomas M., Kipriyanov, Sergey M., Kornacker, Martin, Benner, Axel, Bähre, Alexandra, Stassar, Marike J. J. G., Schäfer, Holger J., Little, Melvyn, Goldschmidt, Hartmut, Cochlovius, Björn

Volltext

Combined effect of recombinant CD19×CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma von Schlenzka, Jana, Moehler, Thomas M, Kipriyanov, Sergey M, Kornacker, Martin, Benner, Axel, Bähre, Alexandra, Stassar, Marike J. J. G, Schäfer, Holger J, Little, Melvyn, Goldschmidt, Hartmut, Cochlovius, Björn

Volltext

Chimärer ˜anti-Tumor-CD3-ζzeta-Kette-Rezeptor œ[anti-Tumor-CD3-zeta-Kette-Rezeptor] ("T-Body") für die Therapie von humanen B-Zell-Neoplasien

Volltext bestellen

How We Read: Tales, Fury, Nothing, Sound

Volltext